Browse All Autoimmune Market Research Reports
List of reports from Autoimmune
Displaying 1 to 12 (of 12 records)
| Pages: « Last 1 |
|
Autoimmune Technologies, LLC - Product Pipeline Analysis, 2013 Update
May 2013 | By - GlobalData
Summary
Autoimmune Technologies, LLC (Autoimmune) is a biomedical company. The company develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. It develops anti-viral drugs that are designed to prevent viral particles from fusing with target cells. Autoimmune also develops Flufirvitide, influenza drug a...
|
$750 |
|
Autoimmune Drugs Markets in China
May 2013 | By - Asia Market Information & Development Company
China's demand for autoimmune drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012)...
|
$2000 |
|
Autoimmune Disorders - Pipeline Review, H1 2013
Feb 2013 | By - Global Markets Direct
Autoimmune Disorders - Pipeline Review, H1 2013 Summary Global Markets Directs, 'Autoimmune Disorders - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
|
$2000 |
|
Acquired (Autoimmune) Hemolytic Anemia Pipeline Review, H2 2012
Nov 2012 | By - Global Markets Direct
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Acquired (Autoimmune) Hemolytic Anemia Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with...
|
$2000 |
|
Autoimmune Disorders - Pipeline Review, H2 2012
Aug 2012 | By - Global Markets Direct
Autoimmune Disorders Pipeline Review, H2 2012
Global Markets Directs, 'Autoimmune Disorders Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline. This report provides information on the therapeutic development for Autoimmune Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also...
|
$2500 |
|
Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments
Apr 2012 | By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments, which provides insights into autoimmune disease therapeutics market until 2017. The report is built using data and...
|
$3500 |
|
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Feb 2012 | By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research, Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success which provides an insight into different endpoints used in clinical trials in autoimmune disorders. The report examines different aspects of clinical trial...
|
$3500 |
|
Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market
Dec 2011 | By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Monoclonal Antibodies Market to 2017 - Multiple Indication Approvals and the Potential for MAbs in Oncology and Autoimmune Diseases are Re-Shaping the Market which provides insights about monoclonal antibodies sales forecasts until 2017. Monoclonal antibodies markets in the key geographies of the US,...
|
$3500 |
|
Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market
Nov 2011 | By - GBI Research
GBI Researchs report, Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market provides in-depth analysis of the drivers and barriers that affect the global orphan autoimmune disorders. The report analyzes the markets for orphan autoimmune disorders therapeutics in the US, the top five countries in...
|
$3500 |
|
Autoimmune Technologies, LLC - Product Pipeline Analysis
Nov 2011 | By - GlobalData
Autoimmune Technologies, LLC - Product Pipeline Analysis
Summary
Autoimmune Technologies, LLC (Autoimmune) is a biomedical company, based in the US. The company develops medical diagnostic tests, explores disease mechanisms, and investigates therapies for autoimmune diseases and other disorders. It also develops an influenza drug, a blood test to aid in the diagnosis of...
|
$750 |
|
Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment Per Trial has Continued to Decline Over the Past Decade
Sep 2011 | By - GBI Research
GBI Research, the leading business intelligence provider, has released its latest research Clinical Trial Recruitment in Autoimmune Disorders-Average Patient Recruitment per Trial has Continued to Decline Over the Past Decade which provides an insight into clinical trial and patient recruitment in Autoimmune Disorders. The report examines different aspects concerning clinical trial and patient...
|
$3500 |
|
Chinese Markets for Autoimmune Drugs
Feb 2009 | By - Asia Market Information & Development Company
China's demand for Autoimmune Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and...
|
$4000 |
Displaying 1 to 12 (of 12 records)
| Pages: « Last 1 |
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com







